ST山水(600234.SH):森特派斯已通過集中競價減持307.6299萬股
格隆匯 9 月 28日丨ST山水(600234.SH)公佈,森特派斯此次減持計劃的減持期間已屆滿。截至2020年9月28日止,由於市場情況和股價情況等因素,森特派斯通過集中競價方式減持公司股份為307.6299萬股,佔公司總股本比例1.52%。
在此次減持計劃外,森特派斯分別於2020年9月2日、9月3日、9月4日和9月7日進行四筆大宗交易(每筆交易50萬股),共減持公司股票200萬股(佔公司總股本比例0.99%)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.